lunes, 16 de octubre de 2023

FDA approves nivolumab for adjuvant treatment of Stage IIB/C melanoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nivolumab-adjuvant-treatment-stage-iibc-melanoma?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario